Loading
IARC estimates 1,053 new cancer cases and 614 cancer deaths in Barbados in 2024; the commonest new cancers are prostate, colorectum and breast. This page is assembled automatically from OnCo's data: 1 trial with a site there, and says what OnCo does not yet hold.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Prostate | 258 | 102.0 | Prostate cancer |
| Colorectum | 162 | 29.3 | Colorectal cancer |
| Breast | 153 | 60.7 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Corpus uteri | 63 | 20.7 | Endometrial cancer |
| Trachea, bronchus and lung | 48 | 8.3 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Cervix uteri | 34 | 15.2 | Cervical cancer |
| Pancreas | 33 | 5.4 | Pancreatic ductal adenocarcinoma |
| Multiple myeloma | 30 | 5.3 | Multiple myeloma |
| Stomach | 28 | 4.6 | Gastric & gastro-oesophageal junction cancer |
| Leukaemia | 26 | 7.9 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Prostate | 119 | 43.5 | Prostate cancer |
| Colorectum | 84 | 13.7 | Colorectal cancer |
| Breast | 74 | 26.7 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Trachea, bronchus and lung | 45 | 7.8 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Pancreas | 30 | 4.9 | Pancreatic ductal adenocarcinoma |
| Multiple myeloma | 22 | 3.7 | Multiple myeloma |
| Stomach | 22 | 3.5 | Gastric & gastro-oesophageal junction cancer |
| Leukaemia | 21 | 4.3 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Cervix uteri | 20 | 6.9 | Cervical cancer |
| Corpus uteri | 15 | 4.1 | Endometrial cancer |
| Trial | Lead sponsor | ||||
|---|---|---|---|---|---|
| Phase 2 | Not yet recruiting | The University of The West Indies | 3 | 2026-09-22 |
Trial records in OnCo whose ClinicalTrials.gov entry lists at least one site in Barbados, captured 2026-10-07 to 2026-10-07. Recruiting first, then the most recently updated. The status is the study's overall status; whether a site in Barbados is open is on the registry page, under Contacts and Locations.
OnCo holds no institution, company or person in Barbados.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. Barbados is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
Barbados is not among the 60 countries ranked in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.